Lymphoma Specialized Program of Research Excellence Molecular Epidemiology Resource Cohort Study (SPORE MER)
As part of a Lymphoma Specialized Program of Research Excellence (SPORE) programme, the Molecular Epidemiology Resource (MER) was initiated as an observational epidemiology cohort study of prospectively enrolled newly diagnosed lymphoma patients evaluated at the Mayo Clinic (Rochester, Minnesota) and the University of Iowa (Iowa City, Iowa), in the United States of America. At both Mayo Clinic Rochester and the University of Iowa, all consecutive cases of lymphoma, including Hodgkin lymphoma (HL) and chronic lymphocytic leukaemia (CLL), who were within 9 months of their initial diagnosis at presentation, as well as a United States resident aged 18 years and older, were eligible for enrolment from 1 September 2002 to 30 June 2015.
Study design
Cohort - clinical
Number of participants at first data collection
6,972 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2002
Primary Institutions
Mayo Clinic
University of Iowa
Links
No website available
Profile paper DOI
Funders
American Cancer Society (ACS)
Henry J. Predolin Foundation
Leukemia & Lymphoma Society (LLS)
Lymphoma Research Foundation
Mayo Foundation
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – paper or computer assisted
- None
- None
- Healthcare data
- Mortality data
Engagement
Keywords
